The multiple sclerosis lesion: Initiated by a localized hypoperfusion in a central nervous system where mechanisms allowing leukocyte infiltration are readily upregulated?

Medical Hypotheses

Volumn 51, Issue 4, 1998, Pages 299-303

  Juurlink, B H J ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; HYPOXIA INDUCIBLE FACTOR 1; LACTIC ACID; MYELIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

BRAIN BLOOD FLOW; BRAIN PERFUSION; CELL HYPOXIA; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; DEMYELINATION; ENDOTHELIUM CELL; ENVIRONMENTAL FACTOR; GENETICS; GLIA CELL; HUMAN; HYPOGLYCEMIA; LEUKOCYTE; MULTIPLE SCLEROSIS; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; REVIEW; WHITE MATTER;

EID: 0031759882     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(98)90052-4     Document Type: Article

References (41)

1. Juurlink B H J. Type-2 astrocytes have much greater susceptibility to heat stress than type-1 astrocytes. J Neurosci Res 1994; 38: 196-201.
2. Juurlink B H J, Husain J. Hyperthermic injury of oligodendrocyte precursor cells - implications for dysmyelination disorders. Brain Res 1994; 641: 353-356.
3. Husain J, Juurlink B H J. Oligodendroglial precursor cell susceptibility to hypoxia is related to poor ability to cope with reactive oxygen species. Brain Res 1995; 698: 86-94.
4. Juurlink B H J. Response of glial cells to ischemia: roles of reactive oxygen species and glutathione. Neurosci Biobehav Rev 1997; 21: 151-166.
5. Thorburne S K, Juurlink B H J. Low glutathione and high iron govern the susceptibility of oligodendroglial precursors to oxidative stress. J Neurochem 1996; 67: 1014-1022.
6. Black C. Update on Raynaud's phenomenon [editorial]. Br J Hosp Med 1994; 52: 555-557.
7. Pantoni L, Garcia J H, Gutierrez J A. Cerebral white matter is highly vulnerable to ischemia. Stroke 1996; 27: 1641-1646.
8. Hattori H, Takeda M, Kudo T, Nishimura T, Hashimoto S. Cumulative white matter changes in the gerbil brain under chronic cerebral hypoperfusion. Acta Neuropathol Berl 1992; 84: 437-442.
9. Wakita H, Tomimoto H, Akiguchi I, Kimura J. Glial activation and white matter changes in the rat brain induced by chronic cerebral hypoperfusion: an immunohistochemical study. Acta Neuropathol Berl 1994; 87: 484-492.
10. Wakita H, Tomimoto H, Akiguchi I, Kimura J. Protective effect of cyclosporin A on white matter changes in the rat brain after chronic hypoperfusion. Stroke 1995; 26: 1415-1422.
11. Zhang Z G, Chopp M, Tang W X, Jiang N, Zhang R L. Postischemic treatment (2-4 h) with anti-CD11b and anti-CD18 monoclonal antibodies are neuroprotective after transient (2 h) focal cerebral ischemia in the rat. Brain Res 1995; 698: 79-85.
12. Ginsberg M D, Hedley-Whyte E T, Richardson E P. Hypoxicischemic leukoencephalopathy in man. Arch Neurol 1976; 33: 5-14.
13. Ginsberg MD. Delayed neurological deterioration following hypoxia. Adv Neurol 1979; 26: 21-44.
14. Brun A, Englund E. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neuro 1986; 19: 253-262.
15. Babikian V, Ropper A H. Binswanger's disease: a review. Stroke 1987; 18: 2-12.
16. Raine C S. Multiple sclerosis: immune system molecule expression in the central nervous system. J Neuropathol Exp Neurol 1994; 53: 328-337.
17. Raine C S. The immunology of the multiple sclerosis lesion. Ann Neurol 1994; 36: S61-S72.
18. Ozawa K, Suchanek G, Breitschopf H et al. Patterns of oligodendroglia pathology in multiple sclerosis. Brain 1994; 117: 1311-1322.
19. Lassmann H, Suchanek G, Ozawa K. Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis. Ann Neurol 1994; 36: S42-S46.
20. Duquette P, Despault L, Knobler R L et al. Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology 1995; 45: 1277-1285.
21. Hartung H P, Archelos J J, Zielasek J et al. Circulating adhesion molecules and inflammatory mediators in demyelination: a review. Neurology 1995; 45: S22-S32.
22. Cannella B, Raine C S. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol 1995; 37: 424-435.
23. Yamasaki Y, Matsuura N, Shozuhara H, Onodera H, Itoyama Y, Kogure K. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 1995; 26: 676-680.
24. Shiga Y, Onodera H, Kogure K et al. Neutrophil as a mediator of ischemic edema formation in the brain. Neurosci Lett 1991; 125: 110-112.
25. Karakurum M, Shreeniwas R, Chen J et al. Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J Clin Invest 1994; 93: 1564-1570.
26. McDonald W I, Miller D H, Thompson A J. Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? the dilemma of interferon-beta. Ann Neurol 1994; 36: 14-18.
27. Rodriguez M, Scheithauer B W, Forbes G, Kelly P J. Oligodendrocyte injury is an early event in lesions of multiple sclerosis. Mayo Clin Proc 1993; 68: 627-636.
28. Rodriguez M, Scheithauer B. Ultrastructure of multiple sclerosis. Ultrastruct Pathol 1994; 18: 3-13.
29. Arnold D L, Matthews P M, Francis G S, O'Connor J, Antel J P. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol 1992; 31: 235-241.
30. Confort Gouny S, Vion Dury J, Nicoli F et al. A multiparametric data analysis showing the potential of localized proton MR spectroscopy of the brain in the metabolic characterization of neurological diseases. J Neurol Sci 1993; 118: 123-133.
31. Kwon EE, Prineas JW. Blood-brain barrier abnormalities in longstanding multiple sclerosis lesion: an immunohistochemical study. J Neuropathol Exp Neurol 1994; 53: 625-636.
32. Lightman S, McDonald W I, Bird A C et al. Retinal venous sheathing in optic neuritis: its significance for the pathogenesis of multiple sclerosis. Brain 1987; 110: 405-414.
33. Tsukada N, Koh C-S, Yanagisawa N, Okano A, Behan W M, Behan O P. A new model for multiple sclerosis: chronic experimental allergic encephalomyelitis induced by immunization with cerebral endothelial cell membranes. Acta Neuropathol 1987; 73: 259-266.
34. Gottlieb S F, Smith J E, Neubauer R A. The etiology of multiple sclerosis: a new and extended vascular-ischemic model. Med Hypotheses 1990; 33: 23-29.
35. Brosnan CF, Cannella B, Battistini L, Raine CS. Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species. Neurology 1995; 45: S16-S21.
36. Ebers GC, Sadovnick AD, Risch NJ and the Canadian Collaborative Study Group. A genetic basis for familial aggregation in multiple sclerosis. Nature 1995; 377: 150-151.
37. Bell J I, Lathrop G M. Multiple loci for multiple sclerosis. Nat Genet 1996; 13: 377-378.
38. Allen I, Brankin B. Pathogenesis of multiple sclerosis: the immune diathesis and the role of viruses. J Neuropathol Exp Neurol 1993; 52: 95-105.
39. 2 tension. Proc Natl Acad Sci USA 1995; 92: 5510-5514.
40. Wang G L, Semenza G L. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 1995; 270: 1230-1237.
41. Welch W J, Kang H S, Beckmann R P, Mizzen L A. Response of mammalian cells to metabolic stress: changes in cell physiology and structure/function of stress proteins. Curr Top Microbiol Immunol 1991; 167: 31-55.